Literature DB >> 2019611

Fibrin-antibiotic mixtures: an in vitro study assessing the possibility of using a biologic carrier for local drug delivery.

F Greco1, L de Palma, N Spagnolo, A Rossi, N Specchia, A Gigante.   

Abstract

An in vitro study assessing the kinetics of drug release from antibiotic-fibrin seal compounds and the antibacterial efficacy of the delivered drug has been performed. Antibiotic sensitivity and the amount of drug released was measured by means of agar diffusion test. Standard and experimental curves were established for each antibiotic and each bacterial test in order to evaluate the quantities of the drug released during each 24 h period. The reconstitution of lyophilized human fibrin with an aqueous solution containing an antibiotic resulted in only minor modification of the clotting process, with the exception of those solutions containing cefotaxim and mezlocillin which failed to clot altogether and were excluded from further study. The evaluation of the kinetics of elution of the antibiotics from the fibrin clots showed that all of the antibiotics had been almost completely released by 96 h. The delivered amount of each drug was enough to maintain the Minimal Inhibitory Concentration (MIC) until the 4th day of culture for the most of antibiotics, resulting in a prolonged release of the drug.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019611     DOI: 10.1002/jbm.820250104

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  10 in total

Review 1.  Infection and tissue engineering in segmental bone defects--a mini review.

Authors:  Manitha B Nair; James D Kretlow; Antonios G Mikos; F Kurtis Kasper
Journal:  Curr Opin Biotechnol       Date:  2011-02-25       Impact factor: 9.740

2.  Secretion of recombinant human fibrinogen by the murine mammary gland.

Authors:  Stephen P Butler; Tanya K O'Sickey; Susan T Lord; Henryk Lubon; Francis C Gwazdauskas; William H Velander
Journal:  Transgenic Res       Date:  2004-10       Impact factor: 2.788

3.  The possibility of using fibrin-based collagen as an antibiotic delivery system.

Authors:  Junichi Nishimura; Kiyokazu Nakajima; Yoshihito Souma; Tsuyoshi Takahashi; Naoki Ikeguchi; Rei Takenaka; Naoki Shinohara; Toshirou Nishida; Yuichiro Doki; Masaki Mori
Journal:  Surg Today       Date:  2012-06-01       Impact factor: 2.549

4.  The sustained release of antibiotic from freeze-dried fibrin-antibiotic compound and efficacies in a rat model of osteomyelitis.

Authors:  M Itokazu; K Yamamoto; W Y Yang; T Aoki; N Kato; K Watanabe
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

5.  Subverting bacterial resistance using high dose, low solubility antibiotics in fibrin.

Authors:  C J Woolverton; K Huebert; B Burkhart; M MacPhee
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

6.  Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes.

Authors:  S T Boyce; G D Warden; I A Holder
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Plasma Bead Entrapped Liposomes as a Potential Drug Delivery System to Combat Fungal Infections.

Authors:  Munazza Tamkeen Fatima; Zeyaul Islam; Ejaj Ahmad; Mehboob Hoque; Marriam Yamin
Journal:  Molecules       Date:  2022-02-07       Impact factor: 4.411

8.  Impact of local and systemic antimicrobials on leukocyte- and platelet rich fibrin: an in vitro study.

Authors:  S A M Siawasch; C Andrade; A B Castro; W Teughels; A Temmerman; M Quirynen
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

Review 9.  Fibrin as a Multipurpose Physiological Platform for Bone Tissue Engineering and Targeted Delivery of Bioactive Compounds.

Authors:  Bruno Bujoli; Jean-Claude Scimeca; Elise Verron
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321

10.  A novel antimicrobial coating to prevent periprosthetic joint infection.

Authors:  Rita Ramalhete; Robyn Brown; Gordon Blunn; John Skinner; Melanie Coathup; Ian Graney; Anita Sanghani-Kerai
Journal:  Bone Joint Res       Date:  2020-12       Impact factor: 4.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.